PERCEPTIVE ADVISORS LLC
Q2 2024 13F-HR/A Holdings
Net value change ($000)
-1,563,713
(-27.4%)
New positions
21
Sold out positions
19
Turnover %
17.7%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q1 2024
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| IMTX | 45,800 | 95.1% |
| Intra-Cellular Therapies, Inc. | 44,526 | 61.0% |
| CTNM | 27,589 | NEW |
| Merus N.V. | 17,751 | NEW |
| RAPP | 17,403 | NEW |
| PTGX | 15,196 | 52.8% |
| AORT | 15,182 | 26.9% |
| INBX | 15,077 | NEW |
| CGEM | 13,079 | NEW |
| INSM | 12,060 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| Inhibrx, Inc. | -148,793 | -100.0% |
| Fusion Pharmaceuticals Inc. | -145,517 | -100.0% |
| MDT | -85,966 | -69.0% |
| IOVA | -77,642 | -27.2% |
| LYRA | -75,818 | -95.5% |
| SRPT | -68,055 | -100.0% |
| ACLX | -58,904 | -21.5% |
| APGE | -54,056 | -39.5% |
| SLDB | -52,836 | -57.4% |
| FOLD | -52,187 | -15.8% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
8,806
(0.2% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|